AMN Healthcare Services Inc
NYSE: AMN · HEALTHCARE · MEDICAL CARE FACILITIES
Updated 2026-04-30
AMN Healthcare Services Inc (AMN) Stock Valuation Analysis
Fair value estimate, historical valuation range, and quality signals for AMN.
Valued
Valuation reasonably reflects current fundamentals. Limited margin of safety at these levels.
AMN historical valuation range
Where current P/E sits in AMN's own 5Y range.
AMN intrinsic value (DCF)
DCF-based fair value estimate vs current market price.
Intrinsic value calculated using discounted cash flow (DCF) model based on projected free cash flows, discount rate, and terminal growth assumptions. A positive margin of safety indicates the current price is below estimated fair value, providing a cushion against estimation error.
AMN valuation signals
Quick-read green flags, caution flags, and risks based on current metrics.
P/E Ratio — History
P/S Ratio — History
Current: 0.29x
Is AMN overvalued in 2026?
AMN Healthcare Services Inc (AMN) currently trades at $20.47 per share with a market capitalization of $786,655,000.00. Based on our multi-factor framework, the stock trades at a fair valuation with a Smart Value Score of 53/100. This score blends growth quality, financial health, and price attractiveness into a single institutional-grade read.
AMN currently has no meaningful P/E ratio, which typically signals that the company is unprofitable, near breakeven, or emerging from a loss-making period. With a P/S ratio of 0.3x, the market is valuing the company primarily on its revenue rather than its earnings.
Looking at its own history, AMN is currently trading cheaper than 100% of the last 5Y on P/E. This places it in the 0th percentile of its historical range, a level that has historically coincided with attractive entry points.
Our discounted cash flow model estimates AMN's intrinsic value at $85.29 per share, against the current market price of $20.47. This implies a margin of safety of +77.09%. A meaningful cushion exists against model error, making this a reasonable risk-adjusted entry.
Financial quality is a concern. The Piotroski F-Score of 3/9 flags weakening fundamentals that deserve closer scrutiny before the valuation case can be fully trusted.
Bottom line: AMN trades at a fair valuation on our framework, with a Smart Value Score of 53/100. The valuation is defensible but offers no obvious bargain. Patience or a better entry price may reward disciplined buyers.
Frequently asked questions
Is AMN overvalued in 2026?
Based on a Smart Value Score of 53/100, AMN is fairly valued. Price reasonably reflects current fundamentals with limited cushion in either direction.
What is AMN's fair value?
Our DCF model estimates AMN's intrinsic value at $85.29 per share, versus the current price of $20.47. This produces a margin of safety of +77.09%.
What P/E ratio does AMN trade at?
AMN does not have a meaningful P/E ratio at this time, typically a sign of unprofitability or an ongoing earnings transition.
Is AMN a buy based on valuation?
WallStSmart does not issue buy or sell recommendations. Our Smart Value Score of 53/100 reflects the combined read on growth, quality, and price. The profile is balanced. Best suited for investors with an existing thesis.
How does AMN's valuation compare to its history?
On P/E, AMN currently sits in the 0th percentile of its own 5Y range. That is historically cheap relative to where it has traded over the period.
What is AMN's Smart Value Score?
AMN's Smart Value Score is 53/100. The Smart Value Score is a proprietary WallStSmart metric blending growth quality, financial health, and valuation attractiveness into a single 0-100 read. Scores above 75 are rare and indicate strong multi-factor alignment.